Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,361 public trials 406 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations: HonorHealth Scottsdale, Arizona, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory Winship Cancer Institute Atlanta, Georgia, United States

Northwestern University Chicago, Illinois, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations: University of California, San Francisco San Francisco, California, United States

Sarah Cannon Research Institute Denver, Colorado, United States

Northwestern Medicine Cancer Centers Warrenville, Illinois, United States

START Midwest Grand Rapids, Michigan, United States

View Trial Details

Active, Not Recruiting

Eye Plaque Brachytherapy for Ocular Melanoma

NCT06432660

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT05358938

Conditions: Adenocarcinoma, Behavior, Carcinoma, +24 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma

NCT05418972

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Active, Not Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

NCT03543969

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

NCT04645680

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Eye Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

NCT07376317

Conditions: Cutaneous Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: ICESP São Paulo, Brazil

View Trial Details

Active, Not Recruiting

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

NCT03474497

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UC Davis Medical Center Sacramento, California, United States

University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors

NCT05121545

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Sibley Memorial Hospital Washington D.C., District of Columbia, United States

View Trial Details

Nevi and Melanomas

Nevi and Melanomas trial results

Related conditions